Research is being done at the University of Tennessee Health Science Centre to develop a new method of treating ischemic stroke, the leading cause of death in the world.
During a recent study, the University College London-led research team identified an anti-viral gene that impacts the risk of both Alzheimer's disease and severe COVID-19.
